Image Place holder

Mike Alberts, MD, MBA

Specialty: Pulmonology
Sub Specialty: Pulmonary Disease, Critical Care Medicine
Program: Thoracic Oncology


Cancer Focus: Lung Cancer

W. Michael Alberts, MD, MBA is Professor of Oncology and Medicine in the Department of Interdisciplinary Oncology at the University of South Florida College of Medicine in Tampa, Florida.  He is the Chief Medical Officer at the H. Lee Moffitt Cancer Center and Research Institute.  Dr. Alberts received his MD from the University of Illinois.  He completed a residency in Internal Medicine at the Ohio State University and a fellowship program in Pulmonary and Critical Care Medicine at the University of California at San Diego.  Dr. Alberts earned an MBA degree from the University of South Florida.  Dr. Alberts is a Past-President of the American College of Chest Physicians.  Dr. Alberts' research and scholarly interests include the diagnosis and management of lung cancer and the business of medicine.

Education & Training

Board Certification:

  • Internal Medicine - Pulmonary Disease
  • Internal Medicine - Critical Care Medicine


  • University of California, San Diego, California - Pulmonary and Critical Care Medicine


  • Ohio State University Hospital, Columbus, Ohio - Internal Medicine

Medical School:

  • University of Illinois - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Nanavaty P, Alvarez MS, Alberts WM. Lung cancer screening: advantages, controversies, and applications. Cancer Control. 2014 Jan.21(1):9-14. Pubmedid: 24357736.
  • Alberts WM. Introduction to the Third Edition: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May.143(5 Suppl):38S-40S. Pubmedid: 23649431.
  • Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May.143(5 Suppl):7S-37S. Pubmedid: 23649434.
  • Alberts WM. Updated ACCP Guidelines for the diagnosis and management of lung cancer: what are the important changes in recommendations?. Pol Arch Med Wewn. 2008 Jan.118(1-2):4-5. Pubmedid: 18405165.
  • Alberts WM. Pulmonary manifestations of the Churg-Strauss syndrome and related idiopathic small vessel vasculitis syndromes. Curr Opin Pulm Med. 2007 Sep.13(5):445-450. Pubmedid: 17940492.
  • Alberts WM. Introduction: Diagnosis and management of lung cancer: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest. 2007 Sep.132(3 Suppl):20S-22S. Pubmedid: 17873157.
  • Alberts WM. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd Edition). Chest. 2007 Sep.132(3 Suppl):1S-19S. Pubmedid: 17873156.
  • Gray J, Alberts W, Bepler G. Statins and lung cancer risk. Chest. 2007 May.131(5):1274-1275. Pubmedid: 17494775.
  • Alberts W. Follow up and surveillance of the patient with lung cancer: what do you do after surgery?. Respirology. 2007 Jan.12(1):16-21. Pubmedid: 17207020.
  • Alberts W. Eosinophilic interstitial lung disease. Curr Opin Pulm Med. 2004 Sep.10(5):419-424. Pubmedid: 15316442.
  • Nordquist L, Simon G, Cantor A, Alberts W, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarcinoma of the lung. Chest. 2004 Aug.126(2):347-351. Pubmedid: 15302716.
  • Alberts W. Lung disease and the lightest of metals. Chest. 2004.126:1730-1732. Pubmedid: 15596666.
  • Simon G, Ruckdeschel J, Williams C, Cantor A, Antonia S, Haura E, Rocha C, Chiappori A, Wagner H, Robinson L, Sommers E, Alberts M, Bepler G. Gefitinib (ZD1839) in previously treated advanced non-small-cell lung cancer: experience from a single institution. Cancer Control. 2003 Sep.10(5):388-395. Pubmedid: 14581894.
  • Alberts W, Bepler G, Hazelton T, Ruckdeschel J, Williams JH J. Lung cancer. Practice organization. Chest. 2003 Jan.123(1 Suppl):332S-337S. Pubmedid: 12527588.
  • Alberts W. 72-year-old man with fever, skin lesions, and consolidation on chest radiograph. Chest. 2000 Sep.118(3):861-862. Pubmedid: 10988216.
  • Alberts W. Too many journals, too little time. Chest. 2000 Jul.118(1):1. Pubmedid: 10893345.
  • Alberts W. The future and lung cancer: room for optimism?. Cancer Control. 2000 Jan.7(1):13-14. Pubmedid: 10777341.
  • Alberts WM. Divalent cations and bronchodilation in asthma. Crit Care Med. 1999 Jun.27(6):1056-1057. Pubmedid: 10397201.
  • Alberts W. Using inhalation challenge tests to evaluate occupational asthma. J Respir Dis. 1999.20(7):464-465.
  • Alberts W. Reactive airways dysfunction syndrome. Advance For Managers Of Respiratory Care. 1998.7(2):30-34.
  • Alberts W. Pulmonary complications of cancer treatment. Curr Opin Oncol. 1997 Mar.9(2):161-169. Pubmedid: 9161795.
  • Perez JE, Alberts WM, Mamal JJ. Delayed tension pneumothorax after laparoscopy. Surg Laparosc Endosc. 1997 Feb.7(1):70-72. Pubmedid: 9116956.
  • Alberts W. 'Circa Menstrual' rhythmicity and asthma. Chest. 1997 Apr.111(4):840-842. Pubmedid: 9106554.
  • Alberts W. Respiratory hazards and the healthcare worker: physical, radiation, and psychosocial hazards. J Respir Dis. 1997.18(4):406-413. Pubmedid: noPMID.
  • Alberts W. Respiratory hazards and the healthcare worker: infectious hazards. J Respir Dis. 1997.18(5):495-503. Pubmedid: noPMID.
  • Alberts W. Respiratory hazards and the healthcare worker: chemical hazards. J Respir Dis. 1997.18(6):592-602. Pubmedid: noPMID.
  • Alberts W, Brooks S. Reactive airways dysfunction syndrome. Curr Opin Pulm Med. 1996 Mar.2(2):104-110. Pubmedid: 9363124.
  • Alberts W, do Pico G. Reactive airways dysfunction syndrome. Chest. 1996.109(6):1618-1626. Pubmedid: 8769520.
  • Rolfe M, Alberts W. The chronic persistent cough. Compr Ther. 1996.22(10):615-621. Pubmedid: 8950077.
  • Alberts W, Brooks S. Occupational asthma. Serious consequences for workers and employers. Postgrad Med. 1995 Jun.97(6):93-8, 101. Pubmedid: 7777449.
  • Alberts WM, Brooks SM. Occupational asthma. Postgrad Med. 1995 Jun.97(6):93-104. Pubmedid: 29211571.
  • Antonia S, Wagner, Jr. H, Williams, Jr. C, Alberts W, Hubbell D, Robinson L, Hilstro J, Ruckdeschel J. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung. Semin Oncol. 1995 Aug.22(4 Suppl 9):34-37. Pubmedid: 7644926.
  • Alberts W. Business and management training for physicians. CME or the third degree. Chest. 1995.108(6):1711-1717. Pubmedid: 7497784.
  • Brooks S, Alberts W. Occupational asthma. Postgrad Med. 1995.97:91-104. Pubmedid: noPMID.
  • Alberts WM. Indoor air pollution: NO, NO2, CO, and CO2. J Allergy Clin Immun. 1994 Aug.94(2 Pt 2):289-295. Pubmedid: 8077581.
  • Alberts W. Building-related illness: what it is, what you can do. J Respir Dis. 1994.15(10):899-962.
  • Alberts W. Indoor air pollution: NO, NO(2), CO, and CO(2). J Immunol. 1994.94:289-295.
  • Alberts W, Rumbak M, Walsh F. Diagnostic techniques in lung cancer. Cancer Control. 1994.1:446-454.
  • Abel W, Alberts W. Effect of eliminating the same challenge step on the results of bronchoprovocation challenge testing. Chest. 1994.106:125s-125s.
  • Alberts W, Ferris M, Brooks S, Goldman A. The FEF 25-75% and the clinical diagnosis of asthma. Ann Allergy. 1994.73:221-225.
  • Alberts W. Occupational asthma in the respiratory care worker. Respir Care. 1993.38:997-1004.
  • Alberts W. Common causes of occupational asthma. J Respir Dis. 1993.14:564-578.
  • Ferris M, Alberts W. Can the baseline FEF 25-75 predict the results of a methacholine bronchial provocation test?. Am Rev Respir Dis. 1993.147:A829-A829.
  • Ferris M, Alberts W. Reproducibility of recommended indices used to report the response to a methacholine bronchial provocation test. Chest. 1993.104:62s-62s.
  • Alberts WM, Brooks SM. Advances in occupational asthma. Clin Chest Med. 1992 Jun.13(2):281-302. Pubmedid: 1387352.
  • Alberts W, Brooks S. Advances in occupational asthma. Clin Chest Med. 1992.13(2):281-302.
  • Alberts W, Goldman A. Bronchodilator testing "confidence intervals" based on the level of bronchial responsiveness. Chest. 1992.102:737-741.
  • Alberts WM, Colice GC, Hammond MD, Goldman AL. Effect of mild hypoxemia on bronchial responsiveness. Ann Allergy. 1990 Sep.65(3):189-193. Pubmedid: 2403224.
  • Schwab KS, Tonner JA, Burenko M, Alberts WM. Bilateral lung infiltrates in a dialysis patient. Hosp Pract (Off Ed). 1987 Jun.22(6):318-320. Pubmedid: 3108295.
  • Alberts WM, Chandler KW, Solomon DA, Goldman AL. Pulmonary disease caused by Mycobacterium malmoense. Am Rev Respir Dis. 1987 Jun.135(6):1375-1378. Pubmedid: 3592410.
  • Alberts WM, Williams JH, Ramsdell JW. Metabolic acidosis as a presenting feature in acute asthma. Ann Allergy. 1986 Aug.57(2):107-109. Pubmedid: 3090909.
  • Alberts WM, Ferguson PR, Ramsdell JW. Preparation and handling of methacholine chloride testing solutions. Effect of the hygroscopic properties of methacholine. Am Rev Respir Dis. 1983 Mar.127(3):350-351. Pubmedid: 6338784.
  • Alberts W. Occupational asthma. In: Seymour W, ed. Pulmonary: pearls of wisdom. Boston, MA: Boston Medical Publishing; 1999.
  • Alberts W. Physician leadership for quality in a price-competitive world. In: Kaufman R, ed. The business side of medicine: a survival primer for medical students and residents. Tampa, FL: ACPE; 1999.
  • Rumbak M. High altitude and diving lung disease. In: Alberts M, ed. Occupational Lung Disease. Northbrook, IL: American College Of Chest Physicians; 1998.
  • Alberts W. Business and management training for physicians. In: Silver J, ed. The business of medicine. Hanley And Belfus; 1998;293-308.
  • Alberts W. Occupational asthma. In: Pulmonary: pearls of wisdom. Boston, MA: Boston Medical Publishing; 1999.

Patient Comments
Overall Satisfaction

0 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments